Barer & Son Capital

Active

Updated: Apr 2, 2026 ·

Financial History

Total Raised

N/A

Valuation

N/A

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jun 1, 2020	AsclepiX Therapeutics	$35.0M Series A	Perceptive Advisors	Rapha Capital Management
Jun 17, 2019	Viela Bio	$75.0M Series B	HBM Healthcare Investments	Cormorant Asset Management, Goldman Sachs, Temasek, Terra Magnum Capital Partners, Viking Global Investors
Nov 13, 2018	AsclepiX Therapeutics	$5.0M Other Equity	Joshua Barer	Piedmont Capital Partners, Kevin Slawin, Salem Partners, TEDCO

Total Raised

N/A

Valuation

N/A